Gossamer Bio Inc. (GOSS)
Gossamer Bio Statistics
Share Statistics
Gossamer Bio has 227.3M shares outstanding. The number of shares has increased by 0.44% in one year.
| 227.3M |
| 0.44% |
| 0.27% |
| 75.7% |
| n/a |
| 800 |
| 0.05% |
Short Selling Information
The latest short interest is 10.54M, so 4.64% of the outstanding shares have been sold short.
| 10.54M |
| 4.64% |
| 4.94% |
| 7.24 |
Valuation Ratios
The PE ratio is -3.62 and the forward PE ratio is -2.67. Gossamer Bio's PEG ratio is 0.05.
| -3.62 |
| -2.67 |
| 1.78 |
| 0.8 |
| 6.94 |
| -59.01 |
| 0.05 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Gossamer Bio.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 6.88, with a Debt / Equity ratio of 6.88.
| 6.88 |
| 6.88 |
| 6.88 |
| -5.08 |
| -58.5 |
| -5.2 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $796,534.72 |
| $-392,555.56 |
| 144 |
| 0.36 |
| n/a |
Taxes
| 893K |
| -1.61% |
Stock Price Statistics
The stock price has increased by 108.33% in the last 52 weeks. The beta is 1.85, so Gossamer Bio's price volatility has been higher than the market average.
| 1.85 |
| 108.33% |
| 1.03 |
| 0.99 |
| 62.37 |
| 1,587,795 |
Income Statement
In the last 12 months, Gossamer Bio had revenue of 114.7M and earned -56.53M in profits. Earnings per share was -0.25.
| 114.7M |
| 114.7M |
| -59.92M |
| -56.53M |
| -39.97M |
| -44.12M |
| -0.25 |
Balance Sheet
The company has 46.07M in cash and 202.88M in debt, giving a net cash position of -156.81M.
| 46.07M |
| 202.88M |
| -156.81M |
| -1.27B |
| 280.59M |
| 227.25M |
Cash Flow
In the last 12 months, operating cash flow was -3.47M and capital expenditures 0, giving a free cash flow of -3.47M.
| -3.47M |
| n/a |
| -3.47M |
| -0.02 |
Margins
Gross margin is 100%, with operating and profit margins of -52.24% and -49.28%.
| 100% |
| -52.24% |
| -48.5% |
| -49.28% |
| -34.84% |
| -52.24% |
| -3.02% |
Dividends & Yields
GOSS does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for GOSS is $8.5, which is 580% higher than the current price. The consensus rating is "Buy".
| $8.5 |
| 580% |
| Buy |
| 4 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -5.01 |
| 4 |